Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Brand Insights - Thought Leadership | Paid Program | OM1

Understanding Heart Failure through the Real-World Data Lens

ByGary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor, Zhaohui Su, PhD, Vice President of Biostatistics, OM1, Brand Insights Contributor
May 5th 2022

Brand Insights - Thought Leadership | Paid Program

Real-World Data Delivers Dose of Hope for Mental Health in the U.S.

ByCarl D. Marci, M.D., Chief Psychiatrist and Managing Director, Neuroscience, OM1, Brand Insights Contributor
March 15th 2022

Brand Insights - Thought Leadership | Paid Program

Advertisement
Advertisement

Trending on PharmExec

1

M&A Roundup: Johnson & Johnson Collaborates with Sail Biomedicines, Processa Pharmaceuticals Acquires Vidya Therapeutics, Relation Collaborates with GSK

2

Replimune Shares Crash Following FDA Review of Melanoma Treatment

3

When Foreign Investments in Pharma and Biotech Become a National Security Concern

4

Addressing Launch Drift to Optimize Product Launches

5

What FDA's Peptide Decision Means for the Industry

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us